Alfie Health, an AI-powered obesity management tech company, raised a $2.1 million pre-seed round to scale its B2B offering, co-founder Alexander Singh tells Axios exclusively.
Why it matters: The GLP-1 class of weight-loss drugs such as Ozempic have seen a surge in consumer demand — but these treatments are accompanied by high per-person costs and unknown long-term effects.
